FDA.reportPublic FDA data

tasimelteon 4 MG/mL Oral Suspension

RxCUI
2468312
RxNorm name
tasimelteon 4 MG/mL Oral Suspension
Display name
tasimelteon 4 MG/mL Oral Suspension
Full name
tasimelteon 4 MG/mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HetliozTASIMELTEONVanda Pharmaceuticals Inc.ca4a9b63-708e-49e9-8f9b-010625443b902026-08-04Warnings, Adverse reactionsExact identifier
rxcui: 2468312

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ca4a9b63-708e-49e9-8f9b-010625443b90tasimelteon 4 MG/mL Oral Suspension [PSN] · tasimelteon 4 MG/ML Oral Suspension [SCD]213These highlights do not include all the information needed to use HETLIOZ safely and effectively. See full prescribing information for HETLIOZ. HETLIOZ ® (tasimelteon) capsules, for oral use HETLIOZ LQ ™ (tasimelteon) oral suspension Initial U.S. Approval: 201420221221